Manager – Strategy & Operations
Tempus
Manager – Strategy & Operations
Tempus
AI-driven platform for medical data insights
Passionate about precision medicine and advancing the healthcare industry?
Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
The Manager - Strategy & Operations role leads strategic, operational, and commercial initiatives to advance Tempus’ precision medicine and Life Science Sequencing/CDx business. The position owns market and competitive strategy, leads commercial marketing programs, and partners with business development leadership to shape and close complex client proposals. Additionally, the role drives commercial operations across internal teams, builds scalable processes, and leads go-to-market execution for new offerings. This role will also manage and develop associate-level team members.
KEY RESPONSIBILITIES
QUALIFICATIONS
Required:
Preferred:
#LI-DA1
USA: $105,000 - $140,000
The expected salary range may vary for other locations. Actual salary may vary based on qualifications and experience. Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical and other benefits depending on the position.
We are an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Tempus uses AI and data analytics to improve patient care and accelerate drug development in healthcare. Its proprietary platform analyzes medical data and images to provide actionable insights for physicians and to identify gaps in care, while helping pharma and biotech companies discover targets and evaluate treatments. Cancer research is a focus, including a pan-cancer organoid platform for precision medicine and a liquid biopsy assay to profile circulating tumor DNA. Revenue comes from providing platform access and insights to healthcare providers and industry partners, with the goal of advancing personalized medicine and speeding cancer research.
Explore more opportunities at Tempus